These findings are consistent with those of previous studies linking high IMPDH2 expression to adverse prognoses for other malignancies, including colorectal 25, 26 and breast cancers 15, in which IMPDH2 is thought to promote tumor cell proliferation and resistance to apoptosis. Here, IMPDH2 is linked to breast cancer.